Biomerica (BMRA) Other Accumulated Expenses (2020)

Biomerica's (BMRA) quarterly Other Accumulated Expenses came in at $6670.0 in Q2 2020.

Biomerica (BMRA) Other Accumulated Expenses (2020) Analysis & Trends

Biomerica has disclosed Other Accumulated Expenses across 1 years of filings, most recently posting $6670.0 for Q2 2020.

Other Accumulated Expenses for Q2 2020 came in at $6670.0, changed N/A year-over-year; the trailing twelve-month figure through May 2020 was $6670.0 (changed N/A YoY), and the FY2020 annual result was $6670.0, changed N/A from the prior year.
Other Accumulated Expenses came in at $6670.0 for Q2 2020 at Biomerica.
In the past five years, Other Accumulated Expenses ranged from a high of $6670.0 in Q2 2020 to a low of $6670.0 in Q2 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Biomerica	5.57 Mn	4.23 Mn	-44,000.00

Historic Data

Download Data

Date	Value
May 31, 2020	6,670.00